Cue Biopharma CUE
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 6.9 | 103.46 | -1.08 | -5,353 | -5 | |
| 2025Q4 | 9.16 | 90.44 | 0.9 | 1,978 | 2 | |
| 2025Q3 | 21.56 | 103.12 | -2.1 | -7,595 | -7 | |
| 2025Q2 | 20.47 | 102.35 | -2.25 | -8,636 | -8 | |
| 2025Q1 | 27.33 | 101.4 | -4.95 | -12,299 | -12 | |
| 2024Q4 | 32.7 | 102.04 | -3 | -9,633 | -9 | |
| 2024Q3 | 22.72 | 105.25 | -5.1 | -8,816 | -9 | |
| 2024Q2 | 37.2 | 104.29 | -6 | -10,383 | -10 | |
| 2024Q1 | 56.7 | 104.64 | -7.5 | -12,668 | -12 | |
| 2023Q4 | 79.2 | 107 | -8.7 | -13,832 | -13 | |
| 2023Q3 | 69 | 106.53 | -6.9 | -11,421 | -11 | |
| 2023Q2 | 109.5 | 103.17 | -9 | -13,516 | -13 | |
| 2023Q1 | 107.1 | 105.03 | -8.7 | -13,380 | -13 | |
| 2022Q4 | 85.5 | 104.44 | -11.4 | -14,866 | -15 | |
| 2022Q3 | 66.9 | 101.85 | -9 | -11,030 | -11 | |
| 2022Q2 | 74.7 | 100.68 | -11.1 | -13,091 | -13 | |
| 2022Q1 | 146.4 | 100.06 | -13.2 | -14,238 | -14 | |
| 2021Q4 | 339.3 | 100.05 | -7.5 | -7,893 | -8 | |
| 2021Q3 | 437.1 | 100.04 | -12.6 | -12,998 | -13 | |
| 2021Q2 | 349.5 | 100.23 | -9.9 | -10,303 | -10 |